-
Innovation Ranking
NewInnovation Ranking – Cancer Genetics Inc
Vyant Bio Inc (Vyant Bio) is a pharmaceutical company that offers diagnostic products and services enabling precision medicine in the field of oncology. It offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. The company's oncology tests and laboratory services offer critical genomic information to healthcare professionals, biopharma companies and cancer centers. CGI also provides clinical services such as expanding DX, test menu, complete program and summation report. It offers a range of pharmacogenomics testing services for clinical...
-
Product Insights
NewLikelihood of Approval Analysis for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Overview How likely is it that the drugs in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Non Muscle Invasive Bladder Cancer...
-
Product Insights
NewLikelihood of Approval Analysis for Neuroendocrine Cancer
Overview How likely is it that the drugs in Neuroendocrine Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neuroendocrine Cancer Overview A neuroendocrine cancer, often referred as a neuroendocrine tumor...
-
Product Insights
NewLikelihood of Approval Analysis for Thyroid Cancer
Overview How likely is it that the drugs in Thyroid Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thyroid Cancer Overview Thyroid cancer is a cancer that starts in the...
-
Product Insights
NewLikelihood of Approval Analysis for Vaginal Cancer
Overview How likely is it that the drugs in Vaginal Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vaginal Cancer Overview Vaginal cancer is a rare cancer that occurs in...
-
Product Insights
NewLikelihood of Approval Analysis for Vulvar Cancer
Overview How likely is it that the drugs in Vulvar Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vulvar Cancer Overview Vulvar cancer is a rare type of cancer. It...
-
Product Insights
NewLikelihood of Approval Analysis for Oropharyngeal Cancer
Overview How likely is it that the drugs in Oropharyngeal Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Oropharyngeal Cancer Overview Oropharyngeal cancer is a disease in which malignant cells...
-
Product Insights
NewLikelihood of Approval Analysis for Colon Cancer
Overview How likely is it that the drugs in Colon Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Colon Cancer Overview Colon cancer, is a type of cancer that begins...
-
Product Insights
NewLikelihood of Approval Analysis for Anal Cancer
Overview How likely is it that the drugs in Anal Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anal Cancer Overview Anal cancer starts in the anus. Symptoms include rectal...
-
Product Insights
NewLikelihood of Approval Analysis for Medullary Thyroid Cancer
Overview How likely is it that the drugs in Medullary Thyroid Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Medullary Thyroid Cancer Overview Medullary thyroid cancer (MTC) is a rare...